AZD-0328

DB12145InvestigationalSmall molecule

AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.

Mechanism: Pharmacologically active on Neuronal acetylcholine receptor subunit alpha-7
Curator reviewed
Formula / weight: C₁₃H₁₆N₂O · 216.284 g/mol (avg)
Code names: AZD0328

Resolves to

Compound

Structure

InChIKeyOCKIPDMKGPYYJS-ZDUSSCGKSA-NSMILESC1C2=C(O[C@]11CN3CCC1CC3)N=CC=C2

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-0328, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.